A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Mise à jour : Il y a 4 ans
Référence : NCT01126892

Femme et Homme

Extrait

A multicenter, open label study of Nilotinib in CML patients PH + with imatininb resistant in blast crisis, accelerated phase or chronic phase. The main purpose is evaluate the safety and efficacy of Nilotinib.


Critère d'inclusion

  • Chronic myeloid leukemia

Liens